Dianthus Therapeutics, Inc. (DNTH) vs Relay Therapeutics, Inc. (RLAY)
- Dianthus Therapeutics, Inc. DNTH 72.09 −3.27%
- Relay Therapeutics, Inc. RLAY 16.28 −5.90%
Dianthus Therapeutics, Inc. and Relay Therapeutics, Inc. are both Biotechnology companies. Dianthus Therapeutics, Inc. is the larger, with a market value of $4.2B against $3.8B — 1.1× the size. Dianthus Therapeutics, Inc. grew revenue faster over the last twelve months: −60.8% against −74.3%. Relay Therapeutics, Inc. has the higher net margin (−2,594.2% vs −10,097.0%) and the higher return on invested capital (0.00% vs −47.7%). Across the 15 metrics below, Relay Therapeutics, Inc. leads on 8 and Dianthus Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | DNTH | RLAY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (11,441.39%) | (2,815.49%) | 0.00% |
| Net margin | (10,096.95%) | (2,594.20%) | 0.00% |
| Free cash flow margin | (8,177.99%) | (1,924.59%) | 0.00% |
| Return on equity | (26.07%) | (36.77%) | (56.36%) |
| Return on assets | (24.98%) | (33.72%) | (48.04%) |
| Return on invested capital | (47.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack